메뉴 건너뛰기




Volumn 8, Issue 3, 2011, Pages 227-234

Regulating nanomedicine - can the FDA handle it?

Author keywords

Bioequivalence; Combination products; Commercialization; Efficacy; FDA; Food and Drug Administration; Nanomedicine; Nanoparticles; Nanoproduct; Nanoscale technologies; Nanotechnology; Nanotherapeutics; National Institutes of Health; National Nanotechnology Initiative; NIH; Patent and Trademark Office; Patents; PTO; Regulation; Safety

Indexed keywords

NANOMATERIAL;

EID: 79953774517     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720111795256156     Document Type: Review
Times cited : (116)

References (38)
  • 1
    • 34250345167 scopus 로고    scopus 로고
    • Special Report-Patents and Nanomedicine
    • Bawa, R. Special Report-Patents and Nanomedicine. Nanomedicine, 2007, 2(3), 351-374.
    • (2007) Nanomedicine , vol.2 , Issue.3 , pp. 351-374
    • Bawa, R.1
  • 2
    • 85056960457 scopus 로고    scopus 로고
    • Patenting Inventions in Bionanotechnology: A Primer for Scientists and Lawyers
    • In: D. E. Reisner (editor). CRC Press, Boca Raton, FL
    • Bawa, R. Patenting Inventions in Bionanotechnology: A Primer for Scientists and Lawyers. In: D. E. Reisner (editor). Bionanotechnology: Global Prospects. CRC Press, 2009; Boca Raton, FL, 309-337.
    • (2009) Bionanotechnology: Global Prospects , pp. 309-337
    • Bawa, R.1
  • 3
    • 77949536534 scopus 로고    scopus 로고
    • Available at, [Last visited October 15, 2010]
    • National Nanotechnology Initiative. Available at: http://www.nano.gov/ [Last visited October 15, 2010]
    • National Nanotechnology Initiative
  • 5
    • 51449117728 scopus 로고    scopus 로고
    • Nanoparticle-based Therapeutics in Humans: A Survey
    • Bawa, R. Nanoparticle-based Therapeutics in Humans: A Survey. Nanotechnol. Law & Business,2008, 5,135-155.
    • (2008) Nanotechnol. Law & Business , vol.5 , pp. 135-155
    • Bawa, R.1
  • 6
    • 79953796430 scopus 로고    scopus 로고
    • Nanopharmaceuticals
    • Bawa, R. Nanopharmaceuticals. Eur. J. Nanomed., 2010, 3(1), 34-39.
    • (2010) Eur. J. Nanomed. , vol.3 , Issue.1 , pp. 34-39
    • Bawa, R.1
  • 7
    • 61349139614 scopus 로고    scopus 로고
    • Drug Delivery and Nanoparticles: Applications and Hazards
    • De Jong, W.H.; Borm, P.J.A. Drug Delivery and Nanoparticles: Applications and Hazards. Intl. J. Nanomed., 2008, 3, 133-149.
    • (2008) Intl. J. Nanomed. , vol.3 , pp. 133-149
    • de Jong, W.H.1    Borm, P.J.A.2
  • 8
    • 47049099053 scopus 로고    scopus 로고
    • Multifunctional Nanoparticles-Properties and Prospects for Their Use in Human Medicine
    • Sanvicens, N., Marco, M.P. Multifunctional Nanoparticles-Properties and Prospects for Their Use in Human Medicine. Trends in Biotechnol., 2008, 26, 425-433.
    • (2008) Trends in Biotechnol. , vol.26 , pp. 425-433
    • Sanvicens, N.1    Marco, M.P.2
  • 10
    • 51049090204 scopus 로고    scopus 로고
    • Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer
    • Davis, M.E.; Chen, Z.G.; Shin, D.M. Nanoparticle Therapeutics: An Emerging Treatment Modality for Cancer. Nat. Rev. Drug Discovery, 2008, 7, 771-782.
    • (2008) Nat. Rev. Drug Discovery , vol.7 , pp. 771-782
    • Davis, M.E.1    Chen, Z.G.2    Shin, D.M.3
  • 12
    • 34249783121 scopus 로고    scopus 로고
    • Regulatory Issues Surrounding Nanomedicines: Setting the Scene for the Next Generation of Nanopharmaceuticals
    • Gaspar, R. Regulatory Issues Surrounding Nanomedicines: Setting the Scene for the Next Generation of Nanopharmaceuticals. Nanomed., 2007, 2, 143-147.
    • (2007) Nanomed. , vol.2 , pp. 143-147
    • Gaspar, R.1
  • 13
    • 10944238174 scopus 로고    scopus 로고
    • Beyond Biotechnology: FDA Regulation of Nanomedicine
    • Miller, J. Beyond Biotechnology: FDA Regulation of Nanomedicine. Columbia Sci. Technol. Law Rev., 2003, 4, 1-35.
    • (2003) Columbia Sci. Technol. Law Rev. , vol.4 , pp. 1-35
    • Miller, J.1
  • 14
    • 38949088755 scopus 로고    scopus 로고
    • Woodrow Wilson International Center for Scholars, Project on Emerging Nanotechnologies, Washington, DC., Available at, [Last visited October 15, 2010]
    • Taylor, M.R. Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? Woodrow Wilson International Center for Scholars, Project on Emerging Nanotechnologies, Washington, DC., 2006. Available at: http://www.nanotechproject.org/82/10506-regulating-the-products-ofnanotechnology [Last visited October 15, 2010]
    • (2006) Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs?
    • Taylor, M.R.1
  • 16
    • 28644446049 scopus 로고    scopus 로고
    • Nanotechnology: The Size of Things to Come
    • Nov-Dec
    • Rados, C. (2005). Nanotechnology: The Size of Things to Come. FDA Consumer Nov-Dec 40-42.
    • (2005) FDA Consumer , pp. 40-42
    • Rados, C.1
  • 17
    • 68549121460 scopus 로고    scopus 로고
    • Nanotechnology Governance
    • Mendel, F. Nanotechnology Governance. Albany Law Review, 2008, 59, 1323-1329.
    • (2008) Albany Law Review , vol.59 , pp. 1323-1329
    • Mendel, F.1
  • 19
    • 34249939453 scopus 로고    scopus 로고
    • The Need for Rules and Regulations
    • Helmus, M. N. The Need for Rules and Regulations. Natu Nanotechnol., 2007, 2, 333-334.
    • (2007) Natu Nanotechnol. , vol.2 , pp. 333-334
    • Helmus, M.N.1
  • 20
    • 77951436128 scopus 로고    scopus 로고
    • Nanotechnology Patent Proliferation and the Crisis at the US Patent Office
    • Bawa, R. Nanotechnology Patent Proliferation and the Crisis at the US Patent Office. Albany Law J. Sci. Technol., 2007, 17(3), 699-735.
    • (2007) Albany Law J. Sci. Technol. , vol.17 , Issue.3 , pp. 699-735
    • Bawa, R.1
  • 21
    • 85036720961 scopus 로고    scopus 로고
    • 71 Fed. Reg. 46232 (August 11, 2006)
    • 71 Fed. Reg. 46232 (August 11, 2006).
  • 22
    • 85036721495 scopus 로고    scopus 로고
    • 71 Fed. Reg. 46233 (August 11, 2006)
    • 71 Fed. Reg. 46233 (August 11, 2006).
  • 23
    • 5744238688 scopus 로고    scopus 로고
    • The Royal Society and the Royal Academy of Engineering, Available at, [Last visited October 15, 2010]
    • The Royal Society and the Royal Academy of Engineering (2004). Nanoscience and Nanotechnologies: Opportunities and Uncertainties. Available at: http://www.nanotec.org.uk/report/Nano%20report%202004%20fin.pdf [Last visited October 15, 2010]
    • (2004) Nanoscience and Nanotechnologies: Opportunities and Uncertainties
  • 25
    • 85036721003 scopus 로고    scopus 로고
    • Available at, [Last visited October 20, 2010]
    • FDA Nanotechnology Public Meeting (2008). Available at: http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/NanotechnologyTaskForce/ucm129416.htm [Last visited October 20, 2010]
    • (2008) FDA Nanotechnology Public Meeting
  • 26
    • 85036696672 scopus 로고    scopus 로고
    • FDA Process For Nano Drug Review "Adequate, " Official Says
    • October 15, 2010. Available at, [Last visited October 20, 2010]
    • G. K. Shaw. (2010). FDA Process For Nano Drug Review "Adequate, " Official Says. New Haven Independent. October 15, 2010. Available at: http://newhavenindependent.org/index.php/archives/entry/fda_process_for_nano_review_adequate_official_says/ [Last visited October 20, 2010]
    • (2010) New Haven Independent
    • Shaw, G.K.1
  • 27
    • 84906480234 scopus 로고    scopus 로고
    • More regulatory science: FDA chief, Available at, [Last visited July 1, 2010]
    • More regulatory science: FDA chief. (2009). The Scientist Available at: http://www.the-scientist.com/blog/display/55984/#ixzz0oyfRmxGi [Last visited July 1, 2010]
    • (2009) The Scientist
  • 28
    • 79959416954 scopus 로고    scopus 로고
    • FDA, Available at, [Last visited October 20, 2010]
    • FDA (2010). Advancing regulatory science for public health Available at: www. fda.gov/ScienceResearch/SpecialTopics/Regulatory Science/ucm228131.htm [Last visited October 20, 2010]
    • (2010) Advancing regulatory science for public health
  • 30
    • 33750286302 scopus 로고    scopus 로고
    • Can Regulation Be as Innovative as Science and Technology? The FDA's Regulation of Combination Products
    • Foote, S.B.; Berlin, R.J. Can Regulation Be as Innovative as Science and Technology? The FDA's Regulation of Combination Products. Minnesota J. Law, Sci. Technol., 2005, 6, 619-644.
    • (2005) Minnesota J. Law, Sci. Technol. , vol.6 , pp. 619-644
    • Foote, S.B.1    Berlin, R.J.2
  • 31
    • 85036701654 scopus 로고    scopus 로고
    • Available at, [Last visited October 15, 2010]
    • Segal, S.A. (1999). Med. Device & Diag. Ind. Mag. 180, Available at: www. devicelink.com/mddi/archive/99/01/016.html [Last visited October 15, 2010]
    • (1999) Med. Device & Diag. Ind. Mag , pp. 180
    • Segal, S.A.1
  • 32
    • 33750313627 scopus 로고    scopus 로고
    • Nanotechnology and the FDA-What Are the Scientific and Regulatory Considerations for Products Containing Nanomaterials?
    • Sadrieh, N.; Espandiari, P. Nanotechnology and the FDA-What Are the Scientific and Regulatory Considerations for Products Containing Nanomaterials? Nanotechnol. Law & Business, 2006, 3(3), 339-349.
    • (2006) Nanotechnol. Law & Business , vol.3 , Issue.3 , pp. 339-349
    • Sadrieh, N.1    Espandiari, P.2
  • 33
    • 68249158663 scopus 로고    scopus 로고
    • Regulatory and Scientific Barriers to the Safety Evaluation of Medical Nanotechnologies
    • Bhogal, N. Regulatory and Scientific Barriers to the Safety Evaluation of Medical Nanotechnologies. Nanomed., 2009, 4(5), 495-498.
    • (2009) Nanomed. , vol.4 , Issue.5 , pp. 495-498
    • Bhogal, N.1
  • 34
    • 31944451232 scopus 로고    scopus 로고
    • Toxic Potential of Materials at the Nanolevel
    • Nel, A., Xia, T., Mädler, L., Li, N. Toxic Potential of Materials at the Nanolevel. Sci., 2006 311(5761), 622-627.
    • (2006) Sci. , vol.311 , Issue.5761 , pp. 622-627
    • Nel, A.1    Xia, T.2    Mädler, L.3    Li, N.4
  • 35
    • 54349084531 scopus 로고    scopus 로고
    • Use of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs
    • Reed, S.D.; Anstrom, K.J.; Seils, D.M.; Califf, R.M.; Schulman, K.A. Use of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs. Health Affairs 2008, 27(5), 360-370.
    • (2008) Health Affairs , vol.27 , Issue.5 , pp. 360-370
    • Reed, S.D.1    Anstrom, K.J.2    Seils, D.M.3    Califf, R.M.4    Schulman, K.A.5
  • 36
    • 67249097722 scopus 로고    scopus 로고
    • The FDA and Nano: Big Problems with Tiny Technology
    • Fender, J. The FDA and Nano: Big Problems with Tiny Technology. Chicago-Kent Law Review, 83, 1063.
    • Chicago-Kent Law Review , vol.83 , pp. 1063
    • Fender, J.1
  • 37
    • 70349999840 scopus 로고    scopus 로고
    • Hitting the Mark or Falling Short with Nanotechnology Regulation?
    • Ludlow, K.; Bowman, D. M.; Kirk, D. D. Hitting the Mark or Falling Short with Nanotechnology Regulation? Trends in Biotechnol., 2009, 27(11), 615-620.
    • (2009) Trends in Biotechnol. , vol.27 , Issue.11 , pp. 615-620
    • Ludlow, K.1    Bowman, D.M.2    Kirk, D.D.3
  • 38
    • 0005023993 scopus 로고
    • The Construction of Food Biotechnology as a Social Issue
    • In, (Maurer, D. and Sobal, J., eds), Aldine de Gruyter
    • Hoban, T.J. The Construction of Food Biotechnology as a Social Issue. In: Eating Agendas: Food and Nutrition as Social Problems (Maurer, D. and Sobal, J., eds), 1995, pp. 189-212, Aldine de Gruyter.
    • (1995) Eating Agendas: Food and Nutrition as Social Problems , pp. 189-212
    • Hoban, T.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.